Mariangela Maltese

Tocilizumab for COVID-19 Pneumonia in a Patient With Non–Small-cell Lung Cancer Treated With Chemoimmunotherapy

Maria Bonomi, Mariangela Maltese, Matteo Brighenti, Margherita Muri et autres

it (code pays fourni par la source)

Clinical and Molecular Predictors of PD-L1 Expression in Non–Small-Cell Lung Cancer: Systematic Review and Meta-analysis

Fausto Petrelli, Mariangela Maltese, Gianluca Tomasello, Bárbara Conti et autres

it (code pays fourni par la source)

High baseline lymphocyte count is a predictive biomarker of prolonged time to progression in patients with advanced solid tumors receiving checkpoint inhibitors.

Mariangela Maltese, Stefano Panni, Silvia Lazzarelli, Matteo Brighenti et autres

it (code pays fourni par la source)

Clinical factors associated with overall survival (OS) for patients with HER2-positive (HER2+) metastatic breast cancer (MBC) treated with HER2-targeting systemic therapy (HER2Tx)

G. Gullo, Naomi Walsh, Alessandra Zacchia, Lisette Hammond et autres

Use and clinical impact of conventional cytotoxic chemotherapy (CTx) subsequent to immunotherapy in metastatic melanoma

Eoghan Ruadh Malone, Mariangela Maltese, Laoise Coady, L. A. Hammond et autres

ie (code pays fourni par la source)

Delayed initiation of HER2-targeted therapy (HER2Tx) is associated with a higher risk of relapse for early stage (ES) HER2-positive (HER2+) breast cancer (BrCa)

Giuseppe Gullo, Rohit Bose, Naomi Walsh, Mariangela Maltese et autres

ie (code pays fourni par la source)

Abstract P4-14-15: Pre-treatment stromal tumour-infiltrating lymphocytes (S-TILs) are correlated with complete response (CR) to chemotherapy (Chemo) plus trastuzumab (T) in HER2-positive (H+) metastatic breast cancer (MBC)

Giuseppe Gullo, Cecily Quinn, Alessandra Zacchia, D. Fennelly et autres

ie (code pays fourni par la source)

Efficacy and safety of dose-dense modified TCF regimen (TCF-dd) in metastatic or locally advanced gastroesophageal cancer (GEC).

Laura Toppo, Gianluca Tomasello, Wanda Liguigli, Margherita Ratti et autres

it (code pays fourni par la source)

Final analysis of efficacy and safety of dose-dense chemotherapy with modified TCF regimen (TCF-dd) in elderly patients (pts) with metastatic gastric cancer (MGC).

Gianluca Tomasello, Wanda Liguigli, Rossana Poli, Margherita Ratti et autres

it (code pays fourni par la source)

Rate of durable complete remission (CR) using two sequential, dose-dense regimens of cisplatin, gemcitabine, paclitaxel (CGP) followed by m-VAC in patients with metastatic urothelial cancer (mUC).

Matteo Brighenti, Stefano Panni, Bruno Perrucci, Mariangela Maltese et autres

it (code pays fourni par la source)

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by oxaliplatin, folinic acid, 5-fluorouracil, and irinotecan (COFFI) in locally advanced or metastatic gastric cancer (MGC).

Gianluca Tomasello, Wanda Liguigli, Rossana Poli, Federica Negri et autres

it (code pays fourni par la source)